November 03, 2025 16:45 ET | Source: Fulcrum Therapeutics, Inc. ― Pociredir Phase 1b PIONEER Trial Data in Sickle Cell…
BEIJING, Nov. 3, 2025 /PRNewswire/ -- The Annual Conference of Financial Street Forum 2025 concluded on Thursday with a theme…
BEIJING, Oct. 30, 2025 /PRNewswire/ -- The Annual Conference of Financial Street Forum 2025 kicked off here on Monday, bringing…
GREATER DES MOINES, Iowa, Oct. 27, 2025 /PRNewswire/ -- The Greater Des Moines Partnership has announced that bestselling author and…
Austin, Texas, October 25, 2025 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, announced analyses data…
Leiden, the Netherlands, October 20, 2025: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext: PHARM; Nasdaq: PHAR) today announced that 12…
October 19, 2025 10:00 ET | Source: AVACTA GROUP PLC Median progression free survival (PFS) has not been reached in…
Ad hoc announcement pursuant to Article 53 of the SIX listing rules Kuros Biosciences increases the annual guidance for 2025…
Pivotal ADAPT SERON results and interim ADAPT Jr data showcase VYVGART’s potential to treat broad set of myasthenia gravis patientsReal-world…
LONDON, Oct. 09, 2025 (GLOBE NEWSWIRE) -- CloudBees, a world-leading AI-powered enterprise DevOps solution, today announced that CloudBees Unify Continuous…